Caliper Life Reaches New 52-Week High (CALP)

NEW YORK ( TheStreet) -- Caliper Life (Nasdaq: CALP) hit a new 52-week high Thursday as it is currently trading at $8.63, above its previous 52-week high of $8.59 with 11,821 shares traded as of 10:10 a.m. ET. Average volume has been 298,700 shares over the past 30 days.

Caliper Life has a market cap of $446.6 million and is part of the technology sector and electronics industry. Shares are up 33.6% year to date as of the close of trading on Wednesday.

Caliper Life Sciences, Inc. develops and sells life sciences products and services primarily to pharmaceutical, biotechnology, and diagnostics companies, and government and other not-for-profit research institutions in the United States, Europe, and Asia. The company has a P/E ratio of 121.6, equal to the average electronics industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
  • Practice your CALP trading strategies and win cash in our stock game.

TheStreet Ratings rates Caliper Life as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and feeble growth in the company's earnings per share. You can view the full Caliper Life Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

What Is Litecoin? What to Know in 2019

What Is Litecoin? What to Know in 2019

Micron Shares Slip on Mixed Earnings Results

Micron Shares Slip on Mixed Earnings Results

Dow Closes Positive as Stocks Buffeted by Volatile Tuesday Trading

Dow Closes Positive as Stocks Buffeted by Volatile Tuesday Trading

Fed Seen Likely to Raise Rates as Stocks Reel, Trump Rants

Fed Seen Likely to Raise Rates as Stocks Reel, Trump Rants

Striking Options: A Volatile December in Equities with Eyes on the Fed

Striking Options: A Volatile December in Equities with Eyes on the Fed